NWM
GSK icon

Nova Wealth Management’s GSK GSK Stock Holding History

Nova Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.83K Buy
130
+40
+44% +$2.12K ﹤0.01% 429
2026
Q1 		$4.98K Hold
90
– – ﹤0.01% 433
2025
Q4 		$4.43K Hold
90
– – ﹤0.01% 435
2025
Q3 		$3.9K Hold
90
– – ﹤0.01% 440
2025
Q2 		$3.47K Buy
+90
New +$3.44K ﹤0.01% 486

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Nova Wealth Management's GSK Position: Q2 2026 in Review

Nova Wealth Management increased its GSK (GSK) stake by 44% in Q2 2026, buying an estimated $2.12K and bringing the position to 130 shares worth $6.83K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

Nova Wealth Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Nova Wealth Management held 130 shares of GSK worth $6.83K as of Q2 2026.
  • Nova Wealth Management bought 40 GSK shares in Q2 2026, an estimated $2.12K.
  • GSK made up ﹤0.01% of Nova Wealth Management's portfolio in Q2 2026, its #429 holding.
  • Nova Wealth Management first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.